Skip to content

A study of early continuous positive airway pressure in acute respiratory failure in children with impaired immunity

Randomised Study of early Continuous positive airway pressure in Acute Respiratory Failure in children with impaired immunity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN82853500
Enrollment
148
Registered
2012-11-14
Start date
2013-01-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory failure in immune impaired children Respiratory Chronic respiratory failure

Interventions

Current interventions as of 07/07/2014: Intervention group Participants allocated to the intervention group will be admitted to the PICU and receive Continuous Positive

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 07/07/2014: 1. Age less than 18 years 2. Expected to have impaired immunity for at least 3 months as a result of a primary diagnosis, therapy or a combination of both 3. Acute respiratory failure or acute on chronic respiratory failure Previous inclusion criteria: 1. Age less than 16 years 2. Expected to have impaired immunity for at least 3 months as a result of a primary diagnosis, therapy or a combination of both 3. Acute respiratory failure or acute on chronic respiratory failure

Exclusion criteria

Exclusion criteria: 1. Already receiving invasive mechanical ventilation for non-respiratory indications 2. Other acute indication for emergency PICU admission and invasive mechanical ventilation, independent of the degree of respiratory failure (e.g., shock, reduced level of consciousness, seizures), as assessed by the PICU team 3. Recent oesophageal/gastric surgery 4. End-of-life care plan in place with limitation of resuscitation 5. Life expectancy less than 12 months 6. Already receiving treatment on PICU

Design outcomes

Primary

MeasureTime frame
Requirement for intubation and invasive mechanical ventilation within 30 days post-randomisation

Secondary

MeasureTime frame
1. Maximum and aggregate daily organ failure score 2. Mortality at 30 days post-randomisation 3. Requirement for Level 2 or Level 3 respiratory support within 30 days post-randomisation 4. Days free from any ventilator support at 30 days post-randomisation 5. Days free from supplemental oxygen (i.e., above pre-acute respiratory failure requirement) at 30 days post-randomisation 6. Hospital mortality 7. Mortality at 90 days post-randomisation 8. Mortality 1 year post-randomisation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 26, 2026